Pain freedom on their terms, even when taken late into a migraine attack.4-6
*Based on the phase 3, open-label safety study that enrolled 360 patients with migraine, which assessed safety, tolerability, and exploratory efficacy of Trudhesa.4
Pain freedom on their terms, even when taken late into a migraine attack.4-6
*Based on the phase 3, open-label safety study that enrolled 360 patients with migraine, which assessed safety, tolerability, and exploratory efficacy of Trudhesa.4